TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$41.2B
Enterprise value$55.0B
Revenue$16.3B +5.9%
ROIC9.0%
EPS, diluted$7.84 +4.7%
Modern Valuation (EOD)
Market Cap$41.2B
Enterprise Value$55.0B
EV / True FCF—
EV / FCF—
EV / Gross Profit—
EV / EBIT25.20
EV / Sales3.37
P / E (GAAP)30.32
P / FCF—
P / Oper. CF15.54
P / Book6.22
Owner & Cash Yields
True FCF Yield—
FCF Yield—
Owner Earn. Yield—
Earnings Yield3.3%
Shareholder Yield+3.8%
Buyback Yield3.0%
Dividend Yield—
Dividend / sh—
Payout Ratio42%
FCF / sh—
EPS (diluted)$7.84
Compounder & Returns
Rule of 40—
ROIC9.0%
Cash ROIC (CROIC)—
GP / Assets—
ROE20.5%
ROA4.5%
Gross Margin—
Oper. Margin13.4%
Net Margin8.3%
FCF Margin—
True FCF Margin—
Quality & Dilution
Cash Conversion—
Accrual Ratio−4.3%
SBC % of FCF—
SBC % of Rev1.5%
Reinvest. Rate0%
Sales Growth Y/Y+5.9%
Sales 3Y CAGR+4.2%
EPS Growth Y/Y+4.7%
FCF Growth Y/Y—
FCF 3Y CAGR—
Share Change Y/Y−5.4%
Balance Sheet & Scale
Revenue (FY)$16.3B
Gross Profit (FY)—
Oper. Income (FY)$2.2B
GAAP Net Income$1.4B
True FCF (ex-SBC)—
Cash & Equiv$2.0B
Total Debt$15.7B
Net Cash (Debt)$-13.7B
Net Cash % MCap−33.3%
Debt / FCF (yrs)—
Current Ratio0.75164.80M sh
Price & Technicals (EOD)
Perf Week−7.28%
Perf Month−11.68%
Perf Quarter−5.54%
Perf Half Y+46.41%
Perf YTD+39.34%
SMA 20 Dist−7.75%$266.47
SMA 50 Dist−7.89%$266.88
SMA 100 Dist−2.08%$251.05
Window High−12.01%$279.36
Window Low+51.74%$162.00
RSI (14) · Vol32.530%v
Income Distribution & Cash Flow ConversionHow every dollar of IQV revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$13.9B
$14.4B
$15.0B
$15.4B
$16.3B
+5.9%
+4.1%
Research & Development (R&D)
—
—
—
—
$3.3M
—
—
Selling, General & Admin (SG&A)
$2.0B
$2.1B
$2.1B
$2.0B
$2.0B
+0.4%
+0.4%
Operating Income (EBIT) ▸
$1.4B
$1.8B
$2.0B
$2.2B
$2.2B
−0.9%
+11.9%
Interest Expense
$375.0M
$416.0M
$672.0M
$670.0M
$729.0M
+8.8%
+18.1%
Income Tax Expense
$163.0M
$260.0M
$101.0M
$301.0M
$252.0M
−16.3%
+11.5%
GAAP Net Income ▸
$966.0M
$1.1B
$1.4B
$1.4B
$1.4B
−0.9%
+8.9%
Diluted EPS ▸
$4.95
$5.72
$7.29
$7.49
$7.84
+4.7%
+12.2%
Diluted Shares
195.0M
190.6M
186.3M
183.4M
173.5M
−5.4%
−2.9%
Balance Sheet
Cash & Equivalents
$1.4B
$1.2B
$1.4B
$1.7B
$2.0B
+16.3%
+9.7%
Total Current Assets
$4.8B
$5.0B
$5.6B
$5.8B
$6.2B
+7.2%
+7.0%
Total Assets
$24.7B
$25.3B
$26.7B
$26.9B
$29.9B
+11.3%
+4.9%
Total Current Liabilities
$5.2B
$5.6B
$6.5B
$7.0B
$8.3B
+19.9%
+12.3%
Total Debt (Short + Long Term)
$12.1B
$12.7B
$13.7B
$14.0B
$15.7B
+12.5%
+6.7%
Total Liabilities
$18.6B
$19.6B
$20.6B
$20.8B
$23.3B
+11.9%
+5.7%
Stockholders' Equity
$6.0B
$5.8B
$6.1B
$6.1B
$6.6B
+9.3%
+2.3%
Net Cash / (Net Debt)
$-10.8B
$-11.5B
$-12.3B
$-12.3B
$-13.7B
−11.9%
—
Invested Capital
$16.8B
$17.3B
$18.4B
$18.3B
$20.4B
+11.0%
+4.9%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$2.9B
$2.3B
$2.1B
$2.7B
$2.7B
−2.3%
−2.5%
Depreciation & Amortization (D&A)
$1.3B
$1.1B
$1.1B
$1.1B
$1.1B
+2.7%
−2.5%
Stock-Based Compensation (SBC)
$170.0M
$194.0M
$217.0M
$206.0M
$247.0M
+19.9%
+9.8%
Share Repurchases (Buybacks)
$406.0M
$1.2B
$992.0M
$1.4B
$1.2B
−7.9%
+32.3%
Dividends Paid
—
—
—
—
$567.9M
—
—
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
On the Wire
what IQV did at the next close after each story
No Wire story has named IQV yet.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
20 big days in a year, and what we hold on each
A big day is a close more than 3.82% from the one before, three times IQV’s median day (1.27%). On 16 of the 20, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±3.82%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayIQVWhat we hold that dayGroup (median of 4) · each
1 Jan 5, 2026+4.09%
Before our storiesgroup +2.8%, moved with IQV
1Jan 5, 2026+4.09%
Before our stories
+2.8% moved with IQVICLR +4.7 · CRL +2.9 · MEDP +2.8 · INCY +0.4
2 Feb 3, 2026−11.88%
Before our storiesgroup −4.4%, did not move with it
2Feb 3, 2026−11.88%
Before our stories
−4.4% did not move with itICLR −6.0 · CRL −5.5 · MEDP −3.3 · INCY −1.7
3 Feb 5, 2026−10.65%
Resultsgroup −6.3%, moved with IQV
3Feb 5, 2026−10.65%
ResultsFirst close after the Feb 5 results filing
−6.3% moved with IQVICLR −10.9 · CRL −8.9 · MEDP −3.6 · INCY +0.2
4 Feb 10, 2026−5.30%
Before our storiesgroup −7.4%, moved with IQV
4Feb 10, 2026−5.30%
Before our stories
−7.4% moved with IQVMEDP −15.9 · INCY −8.2 · ICLR −6.5 · CRL −2.4
5 Feb 12, 2026−4.70%
Before our storiesgroup −3.1%, moved with IQV
5Feb 12, 2026−4.70%
Before our stories
−3.1% moved with IQVICLR −39.9 · CRL −4.4 · MEDP −1.9 · INCY +1.9
6 Feb 18, 2026+4.03%
Before our storiesgroup +3.0%, moved with IQV
6Feb 18, 2026+4.03%
Before our stories
+3.0% moved with IQVICLR +8.9 · MEDP +4.2 · INCY +1.8 · CRL −0.3
7 Feb 26, 2026+5.39%
Before our storiesgroup +3.4%, moved with IQV
7Feb 26, 2026+5.39%
Before our stories
+3.4% moved with IQVICLR +5.1 · CRL +4.7 · MEDP +2.1 · INCY +0.1
8 Feb 27, 2026+4.79%
Before our storiesgroup +1.5%, did not move with it
8Feb 27, 2026+4.79%
Before our stories
+1.5% did not move with itICLR +1.9 · CRL +1.7 · INCY +1.2 · MEDP +1.0
9 Mar 10, 2026−4.27%
Before our storiesgroup −2.8%, moved with IQV
9Mar 10, 2026−4.27%
Before our stories
−2.8% moved with IQVCRL −5.4 · ICLR −3.1 · MEDP −2.5 · INCY −1.1
10 Mar 12, 2026−5.04%
Before our storiesgroup −7.3%, moved with IQV
10Mar 12, 2026−5.04%
Before our stories
−7.3% moved with IQVCRL −9.6 · ICLR −7.5 · MEDP −7.1 · INCY −2.8
11 Apr 23, 2026−8.29%
Before our storiesgroup −8.6%, moved with IQV
11Apr 23, 2026−8.29%
Before our stories
−8.6% moved with IQVMEDP −22.6 · CRL −9.2 · ICLR −7.9 · INCY −1.3
12 May 5, 2026+9.62%
Resultsgroup +5.4%, moved with IQV
12May 5, 2026+9.62%
ResultsFirst close after the May 5 results filing
+5.4% moved with IQVICLR +8.3 · CRL +7.6 · MEDP +3.2 · INCY +0.3
13 May 28, 2026+9.34%
Before our storiesgroup +7.5%, moved with IQV
13May 28, 2026+9.34%
Before our stories
+7.5% moved with IQVICLR +15.5 · CRL +10.2 · MEDP +4.7 · INCY +0.2
14 Jun 17, 2026−4.74%
Nothing on IQVgroup −0.9%, did not move with it
14Jun 17, 2026−4.74%
Nothing on IQVNo IQV story, brief or results filing in our record that day
−0.9% did not move with itCRL −1.3 · MEDP −1.0 · INCY −0.8 · ICLR −0.2
15 Jun 24, 2026+8.37%
Nothing on IQVgroup +8.3%, moved with IQV
15Jun 24, 2026+8.37%
Nothing on IQVNo IQV story, brief or results filing in our record that day
+8.3% moved with IQVICLR +10.9 · CRL +8.3 · MEDP +8.3 · INCY +3.9
16 Jul 1, 2026+5.17%
Nothing on IQVgroup +0.9%, did not move with it
16Jul 1, 2026+5.17%
Nothing on IQVNo IQV story, brief or results filing in our record that day
+0.9% did not move with itMEDP +2.6 · CRL +1.0 · ICLR +0.8 · INCY +0.4
17 Jul 23, 2026+4.43%
Nothing on IQVgroup +3.3%, moved with IQV
17Jul 23, 2026+4.43%
Nothing on IQVNo IQV story, brief or results filing in our record that day
+3.3% moved with IQVMEDP +14.7 · CRL +4.8 · ICLR +1.8 · INCY +0.8
18 Jul 28, 2026+13.94%
Resultsgroup +7.0%, moved with IQV
18Jul 28, 2026+13.94%
ResultsFirst close after the Jul 28 results filing
+7.0% moved with IQVINCY +9.3 · CRL +7.2 · ICLR +6.8 · MEDP −3.1
19 Jul 30, 2026−3.95%
Nothing on IQVgroup −2.2%, moved with IQV
19Jul 30, 2026−3.95%
Nothing on IQVNo IQV story, brief or results filing in our record that day
−2.2% moved with IQVICLR −7.1 · INCY −3.2 · MEDP −1.1 · CRL −0.1
20 Aug 19, 2026+3.85%
Nothing on IQVgroup +3.6%, moved with IQV
20Aug 19, 2026+3.85%
Nothing on IQVNo IQV story, brief or results filing in our record that day
+3.6% moved with IQVINCY +4.0 · CRL +3.9 · ICLR +3.3 · MEDP +3.0
A story on the same day is not a cause, and a group move is not proof either. Group: the median of INCY, MEDP, CRL and ICLR that day, the largest companies in IQV’s SEC industry; “moved with IQV” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). IQV reports before the open, so day 1 is that day’s close. Each time, day 6 ended on the same side as day 1.
Reported Feb 5, 2026
day 1−10.65%day 6−16.63%
Reported May 5, 2026
day 1+9.62%day 6+8.77%
Reported Jul 28, 2026
day 1+13.94%day 6+7.03%
Reported Oct 27, 2026
day 1−0.75%day 6−4.02%
Next report: expected late January to early FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Oct 27 report: −10.15%. Four reports is a small sample.
Each line is IQV’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
IQV against four same-industry peers, a year at 100
IQV is up 9.3% in a year. Charles River Laboratories International is up 87.5%, Icon 13.5% and Incyte 12.3%. Of these four, only Medpace Holdings (+3.2%) did less. Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in IQV’s SEC industry (Services-Commercial Physical & Biological Research) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.